SCHOOL OF PHARMACY AND PHARMACEUTICAL SCIENCES
2022-2023 ANNUAL REPORT
2022-23 ANNUAL REPORT: DEAN’S MESSAGE Binghamton University’s School of Pharmacy and Pharmaceutical Sciences has seen growth and great achievements in the past year. We’ve had faculty members in the spotlight at the national and international level and a new drug, AGAMREE® (Vamorolone), developed by Dean Kanneboyina Nagaraju and Associate Dean Eric Hoffman, has received US Food and Drug Administration (FDA), the EU’s European Medicines Agency (EMA) and the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) approval for the treatment of Duchenne Muscular Dystrophy (DMD). AGAMREE® is the first and only drug to have received full approval in Europe and the United States to treat patients with DMD. This has been a culmination of almost 20 years of collaborative work, from the concept to approval. In addition, construction is nearing completion of the 18,000-square-foot Research and Development Center connected to our pharmacy building. The R&D Center, which will be completed by the end of 2024, will further support our drug development efforts. Academically, PharmD students excelled in a national-level competition, we saw our third class of Doctor of Pharmacy students graduate, and have enrolled the second cohort of students in our master and PhD programs in pharmaceutical sciences. We can now confidently say we are firmly established as a leading school for students wishing to pursue graduate degrees in pharmacy and pharmaceutical sciences. This 2022-2023 annual report is a comprehensive look at the research presentations, publications, and funding of our faculty, showcasing their exemplary achievements in an ever-changing world. Know that we remain committed to providing exceptional learning experiences to our students, even as we achieve the highest levels in our research initiatives. Sincerely,
Kanneboyina Nagaraju, DVM, PhD Dean and Professor
SOPPS Publications 2022-2023 (July 1, 2022 to June 30, 2023)
Journal Articles Adhikari S, Kumar R, Driver EM, Bowes DA, Ng KT, Sosa-Hernandez JE, Oyervides-Muñoz MA, Melchor-Martínez EM, Martínez-Ruiz M, Coronado-Apodaca KG, Smith T, Bhatnagar A, Piper BJ, McCall KL, Parra-Saldivar R, Barron LP, Halden RU. Occurrence of Z-drugs, benzodiazepines, and ketamine in wastewater in the United States and Mexico during the Covid-19 pandemic. Sci Total Environ. 2022 Oct 12;857(Pt 2):159351. doi: 10.1016/j. scitotenv.2022.159351. Epub ahead of print. PMID: 36243065; PMCID: PMC9595400. Alosaimy S, Lagnf AM, Hobbs ALV, Mubarez M, Kufel WD, Morrisette T, Polisetty RS, Li D, Veve MP, Simon SP, Truong J, Finch N, Venugopalan V, Rico M, Amaya L, Yost C, Cubillos A, Chandler E, Patch M, Smith IMK, Biagi M, Wrin J, Moore WJ, Molina KC, Rebold N, Holger D, Kunz Coyne AJ, Jorgensen S, Witucki P, Tran NN, Davis SL, Sakoulas G, Rybak MJ. Nephrotoxicity of Vancomycin in Combination with Beta-lactam Agents: Ceftolozane-tazobactam vs. Piperacillintazobactam. Clin Infect Dis. 2022 Aug 19:ciac670. doi: 10.1093/cid/ciac670. Epub ahead of print. PMID: 35982631. Anderson KE, Gifeisman RI, Basting JL, Harris DJ, Rajan AR, McCall KL, Piper BJ. High Prescribing and State-Level Variation in Z-Drug Use Among Medicare Patients. Pharmacopsychiatry. 2023 Jun 7. doi: 10.1055/a2085-2299. Epub ahead of print. PMID: 37285910. Bello L, Hoffman EP, Pegoraro E. Is it time
for genetic modifiers to predict prognosis in Duchenne muscular dystrophy? Nat Rev Neurol. 2023 Jul;19(7):410-423. doi: 10.1038/s41582023-00823-0. Epub 2023 Jun 12. PMID: 37308617. Belz SN, Seabury RW, Steele JM, Darko W, Miller CD, Probst LA, Kufel WD. Accuracy of 4 Free Online Dosing Calculators in Predicting the Vancomycin Area Under the Concentration-Time Curve Calculated Using a 2-Point Pharmacokinetic Approach. Ann Pharmacother. 2022 Aug 18:10600280221117256. doi: 10.1177/10600280221117256. Epub ahead of print. PMID: 35979912. Benito RA, Gatusky MH, Panoussi MW, McCall KL, Suparmanian AS, Piper BJ. Thirteenfold variation between states in clozapine prescriptions to United States Medicaid patients. Schizophr Res. 2023 May;255:79-81. doi: 10.1016/j.schres.2023.03.010. Epub 2023 Mar 23. PMID: 36965363. Canessa EH, Spathis R, Novak JS, Beedle A, Nagaraju K, Bello L, Pegoraro E, Hoffman EP, Hathout Y. Characterization of the dystrophin-associated protein complex by mass spectrometry. Mass Spectrom Rev. 2022 Nov 24:e21823. doi: 10.1002/mas.21823. Epub ahead of print. PMID: 36420714. Chen A, Mindrebo JT, Davis TD, Kim WE, Katsuyama Y, Jiang Z, Ohnishi Y, Noel JP, Burkart MD. Mechanism-based crosslinking probes capture the Escherichia coli ketosynthase FabB in conformationally distinct catalytic states. Acta Crystallogr D Struct Biol. 2022 Sep 1;78(Pt 9):1171-1179. doi:
10.1107/S2059798322007434. Epub 2022 Aug 30. PMID: 36048156; PMCID: PMC9435599. Cheng JWM, Colucci V, Kalus JS, Spinler SA. Sodium-Glucose Cotransporter 2 Inhibitors Among Heart Failure With Mildly Reduced and Preserved Ejection Fraction. Ann Pharmacother. 2023 Feb 17:10600280231154021. doi: 10.1177/10600280231154021. Epub ahead of print. PMID: 36800904. Cheung N, Bohan KH. Taking the Mystery out of Choosing a Journal for Publishing Your Manuscript. Pharm Educ. 2022 Sep 28;22(4):7988 doi: 10.46542/pe.2022.224.7988. Chowdhury DA, Jeong MS, Vyas L, Kim J, Cosler LE, Lash DJ, Barone JA, Toscani M, Volino LR. Evaluation of temperature excursions from USP <659> recommendations during mail transit. J Am Pharm Assoc (2003). 2023 Feb 8:S1544-3191(23)00018-3. doi: 10.1016/j.japh.2023.02.002. Epub ahead of print. PMID: 36858884. Clemens PR, Rao VK, Connolly AM, Harper AD, Mah JK, McDonald CM, Smith EC, Zaidman CM, Nakagawa T; CINRG DNHS Investigators, Hoffman EP. Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy. J Neuromuscul Dis. 2022;9(4):493501. doi: 10.3233/JND-220811. PMID: 35634851. Clemens PR, Rao VK, Connolly AM, Harper AD, Mah JK, McDonald CM, Smith EC, Zaidman CM, Nakagawa T; CINRG DNHS Investigators; Hoffman EP. Efficacy and Safety of Viltolarsen in Boys With Duchenne
Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study. J Neuromuscul Dis. 2023;10(3):439-447. doi: 10.3233/JND-221656. PMID: 37005891; PMCID: PMC10200237. Corpuz JC, Patel A, Davis TD, Podust LM, McCammon JA, Burkart MD. Essential Role of Loop Dynamics in Type II NRPS Biomolecular Recognition. ACS Chem. Biol. 2022 Sep 29. doi: 10.1021/acschembio.2c00523 De la Garza-Rodea AS, Moore SA, ZamoraPineda J, Hoffman EP, Mistry K, Kumar A, Strober JB, Zhao P, Suh JH, Saba JD. Sphingosine Phosphate Lyase Is Upregulated in Duchenne Muscular Dystrophy, and Its Inhibition Early in Life Attenuates Inflammation and Dystrophy in Mdx Mice. Int J Mol Sci. 2022 Jul 8;23(14):7579. doi: 10.3390/ ijms23147579. PMID: 35886926; PMCID: PMC9316262.
Dowd ME, Tang EJ, Yan KT, McCall KL, Piper BJ. Reductions and pronounced regional differences in morphine distribution in the United States. Res Social Adm Pharm. 2023 Jun;19(6):926-930. doi: 10.1016/j. sapharm.2023.03.003. Epub 2023 Mar 5. PMID: 36894400. Edwards KA, Randall EA, Wolfe PC, Angert ER, Kraft CE. Dietary factors potentially impacting thiaminase I-mediated thiamine deficiency. Sci Rep. 2023 Apr 28;13(1):7008. doi: 10.1038/s41598-023-34063-5. PMID: 37117240; PMCID: PMC10147936. Eufemio CM, Hagedorn JD, McCall KL, Piper BJ. An Analysis of Oxycodone and Hydrocodone Distribution Trends in Delaware, Maryland, and Virginia Between 2006 and 2014. Cureus. 2023 Apr 27;15(4):e38211. doi: 10.7759/cureus.38211. PMID: 37252511; PMCID: PMC10224754.
Colorectal Surgery: A Retrospective, SingleCenter Analysis. Surg Infect (Larchmt). 2023 Mar;24(2):177-182. doi: 10.1089/sur.2022.253. Epub 2023 Jan 31. PMID: 36723503. Guglieri M, Clemens PR, Perlman SJ, Smith EC, Horrocks I, Finkel RS, Mah JK, Deconinck N, Goemans N, Haberlova J, Straub V, MengleGaw LJ, Schwartz BD, Harper AD, Shieh PB, De Waele L, Castro D, Yang ML, Ryan MM, McDonald CM, Tulinius M, Webster R, McMillan HJ, Kuntz NL, Rao VK, Baranello G, Spinty S, Childs AM, Sbrocchi AM, Selby KA, Monduy M, Nevo Y, Vilchez-Padilla JJ, Nascimento-Osorio A, Niks EH, de Groot IJM, Katsalouli M, James MK, van den Anker J, Damsker JM, Ahmet A, Ward LM, Jaros M, Shale P, Dang UJ, Hoffman EP. Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial. JAMA Neurol. 2022 Oct 1;79(10):1005-1014. doi: 10.1001/ jamaneurol.2022.2480. PMID: 36036925; PMCID: PMC9425287.
DiMario A, McCall KL, Couture S, Boynton W. Pharmacist and Pharmacy Technician Attitudes and Experiences with TechnicianAdministered Immunizations. Vaccines (Basel). 2022 Aug 19;10(8):1354. doi: 10.3390/ vaccines10081354. PMID: 36016241; PMCID: PMC9412918.
Fang S, Brems BM, Olawode EO, Miller JT, Brooks TA, Tumey LN. Design and Characterization of Immune-Stimulating Imidazo[4,5-c]quinoline Antibody-Drug Conjugates. Mol Pharm. 2022 Jul 29. doi: 10.1021/acs.molpharmaceut.2c00392. Epub ahead of print. PMID: 35904247.
Doughty B, Fink A, Sellaouti B, Stasko J, Surdi H, Prabhu S. Assessment of an integrated psychiatric pharmacy practice within a rural internal medicine clinic. J Am Pharm Assoc. 2023 Mar-Apr;63(2):655-60. https://doi.org/10.1016/j.japh.2022.09.014
Fang Y, McDonald CM, Clemens PR, Gordish HD, Illei K, Hoffman EP; CINRG DNHS and Vamorolone 002/003/LTE Investigators; Dang UJ. Modeling Early Heterogeneous Rates of Progression in Boys with Duchenne Muscular Dystrophy. J Neuromuscul Dis. 2023;10(3):349-364. doi: 10.3233/JND-221527. PMID: 36806514.
Hassoun N, Cosler L. Global Health Impact: A Model to Alleviate the Burden and Expand Access to Treatment of Neglected Tropical Diseases. Am J Trop Med Hyg. 2023 Feb 27;108(4):801-806. doi: 10.4269/ ajtmh.21-0583. PMID: 36848896; PMCID: PMC10077003.
Field AM, Seabury RW, Kufel WD, Darko W, Miller CD, Mastro KA, Steele JM. SingleDose Antibiotic Prophylaxis with Ertapenem Increases Compliance with Recommendations for Surgical Antibiotic Prophylaxis in Elective
Hitchcock AM, Seabury RW, Kufel WD, Farooqi S, Steele JM, Darko W, Miller CD, Feldman EA. Does a Positive MethicillinResistant Staphylococcus aureus (MRSA) Nasal Screen Predict the Risk for MRSA Skin and Soft Tissue Infection? Ann Pharmacother.
Doughty B, Young S, Eggleston W. Assessment of a comprehensive naloxone education program’s impact on community member knowledge and attitudes on a college campus. J Am Coll Health. 2022 Jul;70(5):13321335. doi: 10.1080/07448481.2020.1807992. Epub 2020 Sep 2. PMID: 32877623.
Harrison LR, Arnet RE, Ramos AS, Chinga PA, Anthony TR, Boyle JM, McCall KL, Nichols SD, Piper BJ. Pronounced Declines in Meperidine in the US: Is the End Imminent? Pharmacy (Basel). 2022 Nov 20;10(6):154. doi: 10.3390/ pharmacy10060154. PMID: 36412830.
2022 Oct 2:10600280221127389. doi: 10.1177/10600280221127389. Epub ahead of print. PMID: 36189671. Holman J, Hurd M, Moses PL, Mawe GM, Zhang T, Ishaq SL, Li Y. Interplay of broccoli/broccoli sprout bioactives with gut microbiota in reducing inflammation in inflammatory bowel diseases. J Nutr Biochem. 2022 Nov 26;113:109238. doi: 10.1016/j. jnutbio.2022.109238. Epub ahead of print. PMID: 36442719.
Accumulation and Retention at the Site of Myocardial Infarction. Adv Healthc Mater. 2023 Feb;12(4):e2201094. doi: 10.1002/ adhm.202201094. Epub 2022 Dec 3. PMID: 36349814; PMCID: PMC10353854. Kaufman DE, Kennalley AL, McCall KL, Piper BJ. Examination of methadone involved overdoses during the COVID-19 pandemic. Forensic Sci Int. 2023 Mar;344:111579. doi: 10.1016/j.forsciint.2023.111579. Epub 2023 Jan 31. PMID: 36739850; PMCID: PMC9886385.
Honfozo A, Ghouli R, Alayi TD, Ouldali M, Arteni AA, Atindehou CM, Fanou LA, Hathout Y, Zinn-Justin S, Tomavo S. The luminal domain of Toxoplasma gondii sortilin adopts a ring-shaped structure exhibiting motifs specific to apicomplexan parasites. Front Parasitol. 2023 Jan 30;2. doi: 10.3389/ fpara.2023.1103772.
Kauzor K, Drewel M, Gonzalez H, Rattinger GB, Hammond AG, Wengreen H, Lyketsos CG, Tschanz JT. Malnutrition and neuropsychiatric symptoms in dementia: the Cache County Dementia Progression Study. Int Psychogeriatr. 2023 May 29:1-11. doi: 10.1017/ S1041610223000467. Epub ahead of print. PMID: 37246509.
Huntley M, McCall K, Stickney K, Gelinas A, Levesque E. Avoidance of drug interactions with hepatitis C treatment: Evaluation of pharmacist interventions in the specialty setting. J Am Pharm Assoc (2003). 2022 Sep-Oct;62(5):1671-1674. doi: 10.1016/j. japh.2022.04.015. Epub 2022 Apr 26. PMID: 35589531.
Kelley EF, Cross TJ, McDonald CM, Investigators C, Hoffman EP, Spurney CF, Bello L. Influence of β1 Adrenergic Receptor Genotype on Longitudinal Measures of Left Ventricular Ejection Fraction and Responsiveness to ß-Blocker Therapy in Patients With Duchenne Muscular Dystrophy. Clin Med Insights Cardiol. 2022 Aug 23;16:11795468221116838. doi: 10.1177/11795468221116838. PMID: 36046180; PMCID: PMC9421016.
Jackson CP, Fang S, Benjamin SR, Alayi T, Hathout Y, Gillen SM, Handel JP, Brems BM, Howe JM, Tumey LN. Evaluation of an ester-linked immunosuppressive payload: A case study in understanding the stability and cleavability of ester-containing ADC linkers. Bioorg Med Chem Lett. 2022 Nov 1;75:128953. doi: 10.1016/j.bmcl.2022.128953. Epub 2022 Sep 1. PMID: 36058468. Jasiewicz NE, Mei KC, Oh HM, Chansoria P, Hendy DA, Bonacquisti EE, Bachelder EM, Ainslie KM, Yin H, Qian L, Jensen BC, Nguyen J. ZipperCells Exhibit Enhanced
Klosko RC, Arnold JR, Murphy CV, Brimmer J, Hagy N, Exline MC, McLaughlin E, Elefritz JL. Early onset delirium incidence and risk factors in hematology oncology patients admitted to the intensive care unit: A retrospective cohort study. Int J Crit Illn Inj Sci. 2022 Oct-Dec;12(4):190-196. doi: 10.4103/ ijciis.ijciis_35_22. Epub 2022 Dec 26. PMID: 36779215; PMCID: PMC9910111. Klosko RC, Lynch SE, Cabral DL, Nagaraju K,
Johnston YA, Steinberg JD, McCall KL. Death and Disability Reported with Cases of Vaccine Anaphylaxis Stratified by Administration Setting: An Analysis of the Vaccine Adverse Event Reporting System from 2017 to 2022. Vaccines (Basel). 2023 Jan 28;11(2):276. doi: 10.3390/vaccines11020276. PMID: 36851154; PMCID: PMC9962937. Kufel WD, Abouelhassan Y, Steele JM, Gutierrez RL, Perwez T, Bourdages G, Nicolau DP. Plasma and cerebrospinal fluid concentrations of cefiderocol during successful treatment of carbapenem-resistant Acinetobacter baumannii meningitis. J Antimicrob Chemother. 2022 Jul 23:dkac248. doi: 10.1093/jac/dkac248. Epub ahead of print. PMID: 35869778. Kufel WD, Blaine BE, Avery LM. Pharmacy students’ knowledge and confidence of COVID-19 following an interactive didactic class. J Am Coll Clin Pharm. 2022 Jul 13:10.1002/ jac5.1678. doi: 10.1002/jac5.1678. Epub ahead of print. PMID: 35942356; PMCID: PMC9349623. Kufel WD, Hitchcock AM, Delbalso AN, Paolino KM. Evaluation of fidaxomicin use in patients with a macrolide allergy/intolerance. J Antimicrob Chemother. 2023 Apr 3;78(4):1127-1128. doi: 10.1093/jac/dkad036. PMID: 36790902. Kufel WD, Parsels KA, Blaine BE, Steele JM, Mahapatra R, Paolino KM, Thomas SJ. Vancomycin plus ceftaroline for persistent methicillin-resistant Staphylococcus aureus bacteremia. Pharmacotherapy. 2022 Nov 12. doi: 10.1002/phar.2741. Epub ahead of print. PMID: 36371648. Kufel WD, Parsels KA, Blaine BE, Steele JM, Seabury RW, Asiago-Reddy EA. Real-world evaluation of linezolid-associated serotonin
toxicity with and without concurrent serotonergic agents. Int J Antimicrob Agents. 2023 Jul;62(1):106843. doi: 10.1016/j. ijantimicag.2023.106843. Epub 2023 May 7. PMID: 37160238. Lebovitz L, Chen AMH, Carey L, Carter JT, Kelsch MP, Ray ME, Spinler SA, Sobieraj DM. A Description of NAPLEX and MPJE Preparation Strategies Among US Colleges and Schools of Pharmacy. Am J Pharm Educ. 2023 Jun;87(6):100067. doi: 10.1016/j. ajpe.2023.100067. Epub 2023 Mar 15. PMID: 37316127. Leppien EE, Doughty BJ, Hurd KL, Strong KN, Piper BJ, McCall KL. Newer Antiseizure Medications and Suicidality: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) Database. Clin Drug Investig. 2023 Jun;43(6):393-399. doi: 10.1007/ s40261-023-01272-9. Epub 2023 May 15. PMID: 37184612. Levine GN, McEvoy JW, Fang JC, Ibeh C, McCarthy CP, Misra A, Shah ZI, Shenoy C, Spinler SA, Vallurupalli S, Lip GYH; American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Stroke Council. Management of Patients at Risk for and With Left Ventricular Thrombus: A Scientific Statement From the American Heart Association. Circulation. 2022 Sep 15:101161CIR0000000000001092. doi: 10.1161/ CIR.0000000000001092. Epub ahead of print. PMID: 36106537. Liu EY, McCall KL, Piper BJ. Variation in adverse drug events of opioids in the United States. Front Pharmacol. 2023 Mar 24;14:1163976. doi: 10.3389/fphar.2023.1163976. PMID: 37033633; PMCID: PMC10079914. Lynch S, Garton C, Fiscus J, Kovnat S,
Woznicki C, Ali H, Cosler LE. Pharmacist prescribed hormonal contraceptives in New York State: Is there a need and an interest? J Am Pharm Assoc (2003). 2023 Jun 7:S1544-3191(23)00169-3. doi: 10.1016/j. japh.2023.06.002. Epub ahead of print. PMID: 37295493. Maybee DV, Ink NL, Ali MAM. Novel Roles of MT1-MMP and MMP-2: Beyond the Extracellular Milieu. Int J Mol Sci. 2022 Aug 23;23(17):9513. doi: 10.3390/ijms23179513. PMID: 36076910; PMCID: PMC9455801. Maybee DV, Psaras AM, Brooks TA, Ali MAM. RYBP Sensitizes Cancer Cells to PARP Inhibitors by Regulating ATM Activity. Int J Mol Sci. 2022 Oct 4;23(19):11764. doi: 10.3390/ ijms231911764. PMID: 36233063; PMCID: PMC9570458. McCall KL, Dube AJ, Stickney K, Gelinas A. Specialty Pharmacy Disease Screening and Routine Assessments for Patients with Rheumatoid Arthritis and Psoriasis. Int J Clin Expl Dermatol. 2022 Jul 15;7(2):46-52. Mei KC, Stiepel RT, Bonacquisti E, Jasiewicz NE, Chaudhari AP, Tiwade PB, Bachelder EM, Ainslie KM, Fenton OS, Nguyen J. Singletailed heterocyclic carboxamide lipids for macrophage immune-modulation. Biomater Sci. 2023 Apr 11;11(8):2693-2698. doi: 10.1039/ d2bm01804g. PMID: 36994921. Mileto AJ, Rinaldi RJ, Grampp SJ, McCall KL, Piper BJ. Regional differences in buprenorphine distribution in Pennsylvania from 2010 to 2020. The Guthrie Journal. 2022 Dec;74(2). doi: 10.53481/001c.57711. Morales M, Alayi TD, Tawalbeh SM, Sydenstricker AV, Spathis R, Kim H, Nagaraju K, Hathout Y, Rider LG. Urine proteomics by mass spectrometry identifies proteins
involved in key pathogenic pathways in patients with juvenile dermatomyositis. Rheumatology (Oxford). 2023 Jan 20:kead033. doi: 10.1093/rheumatology/kead033. Epub ahead of print. PMID: 36661295. Parkes JE, Boehler JF, Li N, Kendra RM, O’Hanlon TP, Hoffman EP, Peterson JM, Miller FW, Rider LG, Nagaraju K. A novel estrogen receptor 1-sphingomyelin phosphodiesterase acid like 3B pathway mediates rituximab response in myositis patients. Rheumatology (Oxford). 2022 Dec 8:keac687. doi: 10.1093/ rheumatology/keac687. Epub ahead of print. PMID: 36478205. Perrine J, Bennett K, Siegrist E, Bradford C, Schwier NC. Potential Failure of Vancomycin Dosing Using AUC/MIC in a Patient With Purulent MethicillinResistant Staphylococcus aureus Pericarditis. J Pharm Technol. 2023 Apr;39(2):95-98. doi: 10.1177/87551225221149732. Epub 2023 Jan 23. PMID: 37051284; PMCID: PMC10084408. Prykhozhij SV, Caceres L, Ban K, CordeiroSantanach A, Nagaraju K, Hoffman EP, Berman JN. Loss of calpain3b in Zebrafish, a Model of Limb-Girdle Muscular Dystrophy, Increases Susceptibility to Muscle Defects Due to Elevated Muscle Activity. Genes (Basel). 2023 Feb 15;14(2):492. doi: 10.3390/ genes14020492. PMID: 36833417; PMCID: PMC9957097. Psaras AM, Carty RK, Miller JT, Tumey LN, Brooks TA. Indoloquinoline-Mediated Targeted Downregulation of KRAS through Selective Stabilization of the Mid-Promoter G-Quadruplex Structure. Genes (Basel). 2022 Aug 13;13(8):1440. doi: 10.3390/ genes13081440. PMID: 36011352; PMCID: PMC9408018. Ryan M, Bohan KH. An academic pharmacy
section special issue grows from a strategic plan. Pharmacy Education. 2022;22(4):160 162. DOI: https://doi.org/10.46542/ pe.2022.224.160162 Schwier NC, Cornelio CK, Greenlee K, Smith AJ, Wohlford GF. Key Articles and Guidelines in the Management of Pericardial Syndromes. J Pharm Pract. 2023 Jun 12:8971900231152369. doi: 10.1177/08971900231152369. Epub ahead of print. PMID: 37306306. Schwier NC, Stephens K, Johnson PN. Management of Idiopathic Viral Pericarditis in the Pediatric Population. J Pediatr Pharmacol Ther. 2022;27(7):595-608. doi: 10.5863/15516776-27.7.595. Epub 2022 Sep 26. PMID: 36186249; PMCID: PMC9514766. Schwier, NC. What is rilonacept’s role in treating recurrent pericarditis? J Am Acad Physician Assist. 2022 Nov; 35(11):18-19. doi: 10.1097/01.JAA.0000889900.27212.8d Valiuska S, Psaras AM, Noé V, Brooks TA, Ciudad CJ. Targeting MYC Regulation with Polypurine Reverse Hoogsteen Oligonucleotides. Int J Mol Sci. 2022 Dec 26;24(1):378. doi: 10.3390/ijms24010378. PMID: 36613820; PMCID: PMC9820101. Varodayan FP, Pahng AR, Davis TD, Gandhi P, Bajo M, Steinman MQ, Kiosses WB, Blednov YA, Burkart MD, Edwards S, Roberts AJ, Roberto M. Chronic ethanol induces a pro-inflammatory switch in interleukin-1β regulation of GABAergic signaling in the medial prefrontal cortex of male mice. Brain Behav Immun. 2023 May;110:125-139. doi: 10.1016/j.bbi.2023.02.020. Epub 2023 Feb 28. PMID: 36863493; PMCID: PMC10106421.
Professor Wesley Kufel examining microbiologic cell cultures to help determine appropriate antibiotic selection for a patient with an infection.
Wijekoon N, Gonawala L, Ratnayake P, Sirisena D, Gunasekara H, Dissanayake A, Senanayake S, Keshavaraj A, Hathout Y, Steinbusch HWM,
Mohan C, Dalal A, Hoffman E, D de Silva KR. Gene therapy for selected neuromuscular and trinucleotide repeat disorders - An insight to subsume South Asia for multicenter clinical trials. IBRO Neurosci Rep. 2023 Jan 30;14:146153. doi: 10.1016/j.ibneur.2023.01.009. PMID: 36819775; PMCID: PMC9931913. Wolfe PC, Tuske AM, Tillitt DE, Allen F, Edwards KA. Understanding and mitigating thiaminase activity in silver carp. Curr Res Food Sci. 2023 Apr 7;6:100502. doi: 10.1016/j. crfs.2023.100502. PMID: 37377495; PMCID: PMC10290998. Yuan Y, Olawode EO, Tumey LN, Lu F. Visualizing drug-induced lipid accumulation in lysosomes of live cancer cells with stimulated Raman imaging. Biomed Opt Express. 2023 May 8;14(6):2551-2564. doi: 10.1364/BOE.487527. PMID: 37342714; PMCID: PMC10278636. Zhang T, Holman J, McKinstry D, Trindade BC, Eaton KA, Mendoza-Castrejon J, Ho S, Wells E, Yuan H, Wen B, Sun D, Chen GY, Li Y. A steamed broccoli sprout diet preparation that reduces colitis via the gut microbiota. J Nutr Biochem. 2023 Feb;112:109215. doi: 10.1016/j.jnutbio.2022.109215. Epub 2022 Nov 9. Erratum in: J Nutr Biochem. 2023 Jul;117:109340. PMID: 36370930. Zhang T, Zou P, Fang Y, Li Y. Physiologically based pharmacokinetic model to predict drug concentrations of breast cancer resistance protein substrates in milk. Biopharm Drug Dispos. 2022 Oct 20. doi: 10.1002/bdd.2335. Epub ahead of print. PMID: 36265038.
Syndromes. In: Matthias KR, Katz MD, editors. Pharmacotherapy Principles and Practice Study Guide, 6th ed. New York (NY): McGraw-Hill; 2023. Available from: https://ppp.mhmedical. com/cases.aspx?groupid=1170 Klosko RC, Spinler SA. Cardiovascular Disorders: Case 006. Acute Coronary Syndromes. In: Matthias KR, Katz MD, editors. Pharmacotherapy Principles and Practice Study Guide, 6th ed. New York (NY): McGraw-Hill; 2023. Available from: https://ppp.mhmedical. com/cases.aspx?groupid=1170 Kufel WD. Skin and Soft Tissue Infections. In: Bookstaver PB, Faculty Panel, editors. Skin, Soft Tissue, Bone, and Joint Infections and Outpatient Stewardship. American College of Clinical Pharmacy and The American Society of Health-System Pharmacists: May 2023. p3152. Kufel WD. PIT Microcredential: Ambulatory Respiratory Infections. The American Society of Health-System Pharmacists; April 12, 2023. Continuing Education, 2 credit hours. Vest K, Lynch SE. Endometriosis. In: DiPiro JT, Yee GC, Michael Posey LL, Haines ST, Nolin TD, Ellingrod VL. editors. DiPiro’s Pharmacotherapy: A Pathophysiologic Approach. 12th ed. McGraw Hill; 2021. Available from: https:// accesspharmacy-mhmedical-com.proxy.binghamton.edu/content.aspx?bookid=3097&sectionid=268013967
Editorial Contributions Book Chapters Klosko RC, Spinler SA. Cardiovascular Disorders: Case 006. Acute Coronary
Ryan M, Bohan KH, editors. Academic Pharmacy Section Special Issue. Pharmacy Education. 2022;22(4). Available from: https://pharmacyeducation.fip.org/pharmacyeducation/ issue/view/73
Professor Willie Eggleston preparing to train pharmacy students on CPR and provide Basic Life Support.
Our Grant Funding 2022-2023 Tony Davis
Eric Hoffman
L. Nathan Tumey
$249,000
$237,360
$447,528
Interrogation of Microbial Natural Product Methyltransferases
Clinical Trial Readiness for Monitoring Muscle Inflammation in Duchenne Muscular Dystrophy
Optimization of ADCs for the Treatment of Cancer
National Institute of General Medical Sciences
William Eggleston $49,140 Evaluating the Feasibility and Impact of an Overdose Prevention Center in Central New York Catholic Charities of Onondaga County
Yuan Fang $30,250 Multi-omics analyses of lipidomics, proteomics, and mRNA profiles in Duchenne Muscular Dystrophy Foundation to Eradicate Duchenne
Yetrib Hathout
National Center for Advancing Translational Sciences
$308,528
Melissa Morales
Exploiting the Hydrophobic Glycosyl Pocket of lgG1 for Imaging and Drug Delivery Applications
$68,585
National Institute of General Medical Sciences
Defining the ceramide pathway disturbance in dystrophin-deficiency (mouse and human), and treatment response in DMD patients treated with prednisone or vamorolone Foundation to Eradicate Duchenne
Kanneboyina Nagaraju $100,000 Improving muscle weakness by blocking the Interferon signature with anti-viral proteins
$566,481
Myositis Association
Biomarker Signatures for Duchenne Muscular Dystrophy
$541,965
National Inst of Neurological Disorders & Stroke
Heidelberg Pharma Research GmbH
Regenxbio Research Collaboration Agreement Regenxbio Inc. via the Childrens Research Institute
$303,056 Legumain to the rescue: A new ADC linker strategy to address the limitations of cathepsin cleavage National Institute of General Medical Sciences $37,572 Mitigating ADA Through Site-specific Conjugation Technology National Institute of General Medical Sciences
Tao Zhang
OTHER FUNDING
$49,999
Foundation Gifts:
Nanoscale exosomes from broccoli sprouts improve the targeted delivery and therapeutic efficacy of bioactives against imflammatory bowel disease
NACDS Foundation
Department of Agriculture via the University of Maine at Orono
Schorr Family Foundation
$20,000 for the TRUST Program
$50,000 for the Schorr Scholarship
$273,000 In Vitro Assessment of Chemical Mixtureinduced airway Inflammation in Healed and Diseased Lungs Department of Homeland Security via the Georgia Institute of Technology $8,018 Novel Formulation Technology to Enhance Oral Absorption of Waterinsoluble Drugs National Institute of General Medical Science via the University of North Texas Health Science Center $14,682 Harnessing gut microbiota to reduce inflammation using broccoli-sprout diets National Institute of Health via the University of Maine at Orono
Organizations:
Care Compass Network $5,000 for the TRUST Program
SOPPS Research Presentations 2022-2023 (July 1, 2022 – June 30, 2023) Mohammad Ali, PhD
Platform Presentation: Ali MAM. “Nuclear Matrix Metalloproteinase-2 (MMP-2) and Roles in Cancer Cell Migration.” Cancer Research Institute of Northern Alberta (CRINA) Seminar Series. University of Alberta. Edmonton, Alta. Canada. Oct. 26, 2022.
Samantha Benjamin, PhD Student
Tracy Brooks & Nathan Tumey as mentors Poster Presentation: Benjamin SR, Psaras AM, Watson D, Leong KJ, Brooks TA, Tumey LN. “Design, Synthesis, and Characterization of MYC-targeting DNAi with Improved Pharmaceutical Properties.” American Association of Pharmaceutical Scientists Northeast Regional Discussion Group (AAPS NERDG) Annual Meeting. Queens, N.Y. Mar. 31, 2023. Poster Presentation: Benjamin SR, Psaras AM, Watson D, Brooks TA, Tumey LN. “Using Conjugation Technology to Increase the Efficacy and Specificity of a MYC-Inhibiting Oligonucleotide.” Protein Engineering Summit (PEGS). Boston, Mass. May 15-19, 2023.
KarenBeth Bohan, PharmD
Poster Presentation: Cheung N, Bohan KH. “Assessment of Online Modules to lncrease Knowledge of Geriatric Care
in Health Care Professionals.” American Association of Colleges of Pharmacy (AACP) Annual Meeting. Dallas, Tex. July 24, 2022. Poster Presentation: Bohan KH, Rajab K, Pauling EE, Nambatya W. “Ugandan third year versus fourth year pharmacy student knowledge of pharmaceutical care.” International Pharmaceutical Federation (FIP) Word Congress. Seville, Spain. Sept. 19, 2022. Platform Presentation: Lakomski MJ, Bohan KH. “Caring for Refugee Patients - Who, What, Where, When, How & Uganda and Medication Safety.” Continuing education, 2 credit hours. 0134-0000-23-013-L05-P. New York State Council for Health-system Pharmacists (NYSCHP), Central Chapter. Feb. 15, 2023.
Katherine Bradley, P4 Student –
Erin Pauling as mentor Poster Presentation: Bradley K, Cole J, Germano A, Kowalsky L, Pauling EE. “Examining Guideline Directed Prescribing Patterns of Type 2 Diabetes Mellitus Medication Across Various Areas of Practice Pre and Post Pharmacy-Led Educational Intervention.” American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting. Las Vegas, Nev. Dec 5, 2022.
Tracy Brooks, PhD
Poster Presentation: Benjamin S, Psaras AM, Tiszler, JX, Watson D, Leong KJ, Tumey LN, Brooks TA. “Synthesis and optimization of DNAi conjugates targeting the MYC G4.” Gordon Research Conference: Nucleosides, Nucleotides and Oligonucleotides. Newport, R.I. June 27, 2023. Poster Presentation: Elder K, Valiuska S, McKay S, Psaras AM, Noe V, Ciudad CJ, Brooks TA. “Enhanced anti-cancer activity with combinations of MYC and KRAS targeting PPRHs.” Gordon Research Conference: Nucleosides, Nucleotides and Oligonucleotides. Newport, R.I. June 27, 2023.
Danielle Cabral, PharmD
Platform Presentation: Nguyen N, Pao M, Gozar M, Cabral D, Goetz H, Kavanagh R. “Implementation of a pharmacist led long-acting injectable cabotegravir/rilpivirine program for human immunodeficiency virus-1 (HIV-1) at health system-based clinics in the New York metropolitan area.” New York State Council of Health-system Pharmacists (NYSCHP) Annual Assembly. Saratoga Springs, N.Y. Apr. 22, 2023.
Joseph D’Antonio, P4 Student –
Tony Davis as mentor Poster Presentation: D’Antonio J, Kelly E, Halaji Dezfuli M, Gurtata J, Davis
TD. “Development of a Differential Scanning Fluorimetry Assay to Screen for Modulators of the Mycobacterium tuberculosis Prokaryotic Proteasome System.” American Society of HealthSystem Pharmacists (ASHP) Midyear Clinical Meeting. Las Vegas, Nev. Dec 5, 2022; & New York State Council of Health-system Pharmacists (NYSCHP) Annual Assembly. Saratoga Springs, N.Y. Apr. 22, 2023.
Bennett Doughty, PharmD
Platform Presentation: Doughty B. “Healthcare Provider Burnout.” Otsuka’s PsychU Platform. Virtual. July 2022. Poster Presentation: Doughty B, Klosko R, McGinley J, Mogul A, Rouhana N, Seward S, Fahs PS, Young SR, Eggleston W. “The Rural and Underserved Service Track (TRUST): Interprofessional Education Through Underserved Community Engagement.” American Association of Colleges of Pharmacy (AACP) Annual Meeting. Dallas, Tex. July 23, 2022. Platform Presentation: Doughty B. “Strategies to Optimize Patient Outcomes in Bipolar 1 Disorder: The Role of Long-Acting Injectable Antipsychotics.” Otsuka’s PsychU Platform. Virtual. September 2022. Platform Presentation: Doughty B. “Suicide Awareness, Assessment, & Prevention Strategies.” Otsuka’s PsychU Platform. Virtual. September 2022. Platform Presentation: Doughty B, Klosko R, McGinley J, Rouhana N, Young
SR. “The Rural and Underserved Service Track: A Novel Student-Faculty-PatientCommunity Collaboration to Train the Next Generation of Providers.” Nexus Summit 2022. Virtual. Sept. 13 2022. Platform Presentation: Doughty B, Ahmed E. “Treating the Patient with Pain and Concomitant Substance Use Disorder.” American College of Clinical Pharmacy/ New York State Council for Health-system Pharmacists (ACCP/ NYSCHP) Webinar CE. Virtual. Nov. 17, 2022.
C. “AACT Diversity Equity & Inclusion Special Interest Symposium - Where We Are & Where We Are Going-Diversity Equity & Inclusion in Toxicology.” North American Congress of Clinical Toxicology (NACCT). San Francisco, Ca. Sept. 16, 2022.
Siteng Fang, Research Staff
Poster Presentation: Mogul A, Doughty B, Eggleston W. “Evaluating the Impact of an at Home Medication Disposal System on Safe Medication Disposal.” New York State American College of Clinical Pharmacy (NYS ACCP) Annual Meeting. November 2022.
Tracy Brooks & Nathan Tumey as mentors Poster Presentation: Fang S, Brems B, Ojo V, Elder K, Brooks TA, Tumey LN. “Design, Evaluation, and Optimization of Immune Stimulating Antibodydrug Conjugates for Cancer Therapy.” American Association of Pharmaceutical Scientists Northeast Regional Discussion Group (AAPS NERDG) Annual Meeting. Queens, N.Y. Mar. 31, 2023; & Protein Engineering Summit (PEGS). Boston, Mass. May 15-19, 2023.
Katie Edwards, PhD
Yuan Fang, PhD
Platform Presentation: Edwards K. “Connecting Environmental Toxicology with Pharmaceutical Sciences through the Study of a Type 2 Diabetes Medication.” Maine Sustainability and Water Conference. Augusta, Maine. March 27, 2023. Platform Presentation: Edwards K, Randal E, Wolfe P, Angert E, Kraft C. “Potential Impact of Dietary Composition on Thiaminase I-mediated Thiamine Deficiency.” American Fisheries Society Conference. Virtual. Aug. 21, 2023.
William Eggleston, PharmD
Platform Presentation: Winkler G, Olsen K, Banerji S, Eggleston W, Hoyte
Platform Presentation: Fang Y, Chen J, Mez J, Satizabal CL, Alosco ML, Qiu WQ, Doyle MF, Murabito JM, Lunetta KL. “Modeling heterogeneity in cognitive trajectories in the Framingham Heart Study.” Monthly Scientific Progress in Framingham Heart Study Brain Aging Program (FHS-BAP), Pilot Grant Recipient talk. Boston University. Virtual. Mar. 16, 2023. Poster Presentation: Fang Y, McDonald CM, Clemens PR, Gordish-Dressman H, Illei K, Hoffman EP, CINRG DNHS and Vamorolone 002/003/LTE Investigators, Dang UJ. “Modeling early heterogeneity in progression in boys with Duchenne muscular dystrophy.” Muscular Dystrophy
Association Clinical & Scientific Conference. Virtual. Mar. 19, 2023. Platform Presentation: Dai W, Fang Y, Subedi S. “Clustering microbiome data using mixtures of logistic normal multinomial models.” The Classification Society Annual Meeting. University of Rochester Medical Center. Rochester, N.Y. June 17, 2023.
Serena Farnell, P4 Student –
Tony Davis as mentor Poster Presentation: Farnell S, Davis TD. “Design and Synthesis of Tripeptide Inhibitors of the Mycobacterium tuberculosis Prokaryotic Proteasome System.” American Pharmacists Association (APhA) Annual Meeting and Exposition. Phoenix, Ariz. March 24-27, 2023.
Anna Fink, P4 Student –
Bennett Doughty as mentor Poster Presentation: Fink A, Doughty B, Sellaouti B, Stasko J, Surdi H, Prabhu S. “Assessment of an Integrated Psychiatric Pharmacy Practice within a Rural Internal Medicine Clinic.” American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting. Las Vegas, Nev. Dec 5, 2022; & American Academy of Private Physicians (AAPP) Annual Meeting 2023. April 16, 2023.
Jennifer Fiscus, P4 Student –
Sarah Lynch as mentor Poster Presentation: Fiscus J, Garton C, Kovnat S, Woznicki C, Lynch S. “Knowledge and Perceptions of New York State Women Towards Pharmacist
The newly completed Research & Development lab attached to the east end of the pharmacy school.
Prescribed Hormonal Contraception.” American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting. Las Vegas, Nev. Dec 5, 2022.
Deanna Forella, P4 Student –
Wes Kufel as mentor Poster Presentation: Forella DJ, OShea MD, DelBalso AN, Fitzpatrick SR, Kufel WD. “Evaluation of Candiduria Management at an Academic Medical Center.” American Society of HealthSystem Pharmacists (ASHP) Midyear Clinical Meeting. Las Vegas, Nev. Dec. 5, 2022.
Meghan Gray, P3 Student
Poster Presentation: Canessa EH, Naveed A, Tiszler J, Mckay S, Ki Y, Bello L, Pegoraro E, Hathout Y. “Targeted mass spectrometry quantification of the DAPC components and correlation with disease severity in DMD and BMD patients.” MDA Clinical & Scientific Conference 2023. Dallas, Tex. March 3, 2023.
Ryan Kendra, P3 Student
Poster Presentation: Parkes J, Boehler J, Li N, Kendra R. “A Novel Rituximab Pathway to Mediate Myositis Response in Refractory Myositis.” New York Council of Health Systems Pharmacists (NYSCHP) Annual Meeting. Apr. 22, 2023.
Tracy Brooks and Nathan Tumey as mentors Poster Presentation: Gray M, Miller J, Zielinski K, McKay S, Elder K, Brooks TA, Tumey LN. “Pharmacology of LegumainCleavable MMAE Containing ADC Linkers.” Protein Engineering Summit (PEGS). Boston, Mass. May 15-19, 2023.
Rachel Klosko, PharmD
Yetrib Hathout, PhD
Platform Presentation: Klosko R. “Lightning Talk: The Rural and Underserved Services Track (TRUST): A Novel Student-Faculty-PatientCommunity Collaboration to Train the Next Generation of Health Care Providers.” Nexus Summit (Virtual). September 2022.
Platform Presentation: Hathout Y. “Mass Spectrometry Characterization of the Dystrophin Associated Protein Complex.” 8th International Caparica Conference on Analytical Proteomics 2022. Caparica, Portugal. July 18-21, 2022. Platform Presentation: Ogundele M, Dang U, Hoffman EP, Gordish-Dressman H, CINRG-DNHS Investigators, Hathout Y. “Blood accessible biomarkers for Duchenne muscular dystrophy.” European Bioanalysis Forum. Barcelona, Spain. Nov. 16, 2022.
Poster Presentation: Klosko R, Lynch S, Snyder A. “Impact of a High-Fidelity Bedside Management Simulation on Student Confidence with Pneumonia Management.” American Association of Colleges of Pharmacy (AACP) Annual Meeting. Dallas, Tex. July 24, 2022.
Platform Presentation: Klosko R. “A New POV: Angiotensin II for Post-Operative Vasoplegia.” Continuing education, 1 credit hour. New York State - American College of Clinical Pharmacy (NYS-ACCP) Annual Meeting. October 2022.
Platform Presentation: Klosko R. “Surpassing Statins: Updates in Lipid Lowering Therapies.” Continuing education, 1 credit hour. New York Council of Health Systems Pharmacists (NYSCHP) Annual Meeting. Apr. 21, 2023.
Wesley Kufel, PharmD
Platform Presentation: Kufel WD, Rubiconti E, Sipeol R, Khasko A, McKnight M, Parsels KA. “Evaluation of Serotonin Syndrome with Linezolid and Serotonergic Agents at an Academic Medical Center.” IDWeek 2022. Washington, D.C. Oct. 20, 2022. Platform Presentation: Kufel WD. “Vitamin ‘D’oxycycline: Treatment and Prevention of Lyme Disease.” Trudeau Lyme Disease Summit. Trudeau Institute. Saranac Lake, N.Y. Oct. 22, 2022. Platform Presentation: Barbay E, Feldman EA, Kufel WD, Amedeo V, Steele JM, Parsels KA, Miller CD, Darko W, Seabury RW. “Comparison of Teo Empiric ExtendedInfusion Dosing Approaches for PiperacillinTazobactam in Critically Ill Patients: 3.375 Grams Versus 4.5 Grams.” Vizient Meeting. Las Vegas, Nev. Dec. 3, 2022. Platform Presentation: Kufel WD, Paolino KM. “Lyme is Ticking: Updates on the Management of Lyme Disease and Other Tick-Borne Infections.” American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting. Las Vegas, Nev. Dec. 6, 2022. Platform Presentation: Hitchcock AM, Kufel WD, Seabury RW, Steele JM.
“Impact of a Pharmacist-Conducted Preoperative Beta-Lactam Allergy Assessment on Perioperative Cefazolin Prescribing.” New York State Council of Health System Pharmacists (NYSCHP) Annual Assembly, Saratoga Springs, N.Y. Apr. 21, 2023. Platform Presentation: Kufel WD. “Residency Research and Practice Forum: No Time, No Problem: Optimizing Student Research Opportunities to Enhance Productivity for All.” Continuing education, 1 credit hour. New York Council of Health Systems Pharmacists (NYSCHP) Annual Meeting. Apr. 22, 2023.
Emily Leppien, PharmD
Platform Presentation: Leppien EE, Pauling EE. “The Battle Against Social Determinants of Health and Disparities in Pain Management - Part 1.” Continuing education, 1 credit hour. American Pharmacists Association (APhA) Hot Topics Webinar Program. Virtual. Jul. 20, 2022. Platform Presentation: Leppien EE and Garofoli M. «Appropriate Interpretation of Urine Drug Screen Results.» Continuing education, 1 credit hour. American Pharmacists Association and Providers Clinical Support System (APhA and PCSS) Webinar, supported by Substance Abuse and Mental Health Services Administration (SAMHSA). Virtual. Feb. 2, 2023. Platform Presentation: Leppien EE. “’All In’ on Pain Management with Alternative Therapy.” Continuing education, 1 credit
hour. American Pharmacists Association (APhA) Annual Meeting. Phoenix, Ariz. Mar. 24, 2023. Poster Presentation: Leppien EE, Doughty B, Hurd KL, Strong KN, Piper B, McCall KL. “Newer AntiSeizure Medications (ASMs) and Suicidality: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) Database.” New York State Council of Healthsystem Pharmacists (NYSCHP) Annual Assembly. Saratoga Springs, N.Y. Apr. 22, 2023; & American Association of Psychiatric Pharmacists (AAPP) Annual Meeting. Atlanta, Ga. Apr. 17, 2023.
Sarah Lynch, PharmD
Platform Presentation: Rafie S, Lynch S, Williams K. “New York State Pharmacist Contraception Services Training Program.” Continuing education, 2 credit hours. Pharmacists Society of the State of New York (PSSNY)/ Birth Control Pharmacist. Virtual. Platform Presentation: Lynch SE, Pauling EE, Wilson JA, Waghel RC. “Get up and out of the classroom! Innovative active learning strategies for nonprescription medications.” Continuing education, 1 credit hour. American Association of Colleges of Pharmacy (AACP) Annual Meeting. Dallas, Tex. July 25, 2022.
Platform Presentation: Franko TS, Leppien EE, Peppard WJ. “An Interprofessional Conversation on Substance Use Disorders.” American Pharmacists Association Academy of Student Pharmacists (APhA-ASP) Expert Panel Webinar. Virtual. Apr. 25, 2023.
Platform Presentation: Lynch S, Nuziale B, Tran D. “Bridging the Gap: Intentionally Connecting Skills Lab Courses, Experiential Learning, and Pharmacy Practice.” American Association of Colleges of Pharmacy (AACP) Annual Meeting. Dallas, Tex. July 26, 2022.
Platform Presentation: Leppien EE. “Opioid Use Disorder: Beyond the Medicine.” Continuing education, 1.5 credit hours. Florida Pharmacy Association Summit on Substance Use Disorders. Virtual. May 20, 2023.
Keynote Presentation: Lynch S. “At the Corner of Happy and Healthy: The Increasing Scope of Pharmacists and what this means for Healthcare.” Upstate New York Science Librarians Annual Conference. Binghamton, N.Y. October 2022.
Mia Lussier, PharmD
Platform Presentation: Mia Lussier. “Use of guideline-concordant diabetes medications in an elderly population: a mixed-methods study.” American College of Clinical Pharmacy (ACCP) Annual Meeting. Invited Research Fellowship Platform Presentation. October 2022.
Platform Presentation: Lynch S, Stilling W. “The Dobbs Decision: Impact for Pharmacists. American Pharmacists Association (APhA) Annual Meeting. Phoenix, Ariz. March 2023.
Melissa Morales, PhD
Poster Presentation: Morales, M, Parkes J, Narvesen S, Spathis R. “Effect of Type I IFN on Mitochondria and Muscle Weakness in Myositis.” American College of Rheumatology (ACR) Annual Meeting. Virtual. Nov. 12, 2022. Poster Presentation: Morales M, Spathis R, Narvesen S, Robles Kuriplach D, Huang K, Sundar T, Shulman D, Bagley E, Nagaraju K. “Effect of JAK-STAT Inhibition by Tofacitinib and Baricitinib on disease phenotype in a Mouse Model of Juvenile Myositis.” Cure Juvenile Myositis (JM) Annual Patient Conference. Gaithersburg, Md. June 30, 2023.
Kanneboyina Nagaraju, PhD
Platform Presentation: Nagaraju K. “Role of type I interferon in myositis.” The Myositis Association annual patient conference - MAB symposium. Virtual. Sep. 9, 2022. Panel moderator: “Behind the Scenes: A Look at the Experience of Pharmacists and Pharmacist Educators during the COVID-19 Pandemic.” International Conference on Disaster Management: Global Pandemic and its impact. Binghamton, N.Y. Jan. 25-27, 2023.
A behind-the-scenes look at the high-fidelity manikins and system used to control them.
Platform Presentation: Nagaraju K. “Revising and revisiting Preclinical Standard operating procedures for neuromuscular disease models.” TREATNMD SOP Meeting. Amsterdam, The Netherlands, March 1-5, 2023.
Victor Ojo, Research Volunteer – Nathan Tumey as mentor Poster Presentation: Ojo V, Tumey LN. “Novel Dual-loaded ADC elicits both cytotoxic and immune-modulating effects in in-vitro pancreatic cancer model.” Protein Engineering Summit (PEGS). Boston, Mass. May 15-19, 2023.
Platform Presentation: Coleman MD, Pauling EE. “The Crossroads in Diabetes Care: Social Determinants of Health.” American Pharmacists Association (APhA) Annual Meeting and Exposition. Phoenix, Ariz. Mar. 27, 2023.
Kevin Perdue, P4 Student –
Tracy Brooks as mentor Poster Presentation: Patafio D, Psaras AM, Brooks TA. “Role of Physiologically Relevant Conditions in Hormone Receptor Positive Breast Cancer Responsiveness to Chemotherapy.” American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting. Las Vegas, Nev. Dec 5, 2022.
Danielle Cabral as mentor Poster Presentation: Perdue K, Ahmed N, Kaur G, Hashmi M, Cabral D. “Assessing the Need for HIV PreExposure Prophylaxis (PrEP) in Individuals with Sexually Transmitted Infections (STIs) in a Large Tertiary Medical Center.” American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting. Las Vegas, Nev. Dec. 5, 2022.
Nikil Patel, P4 Student –
Gail Rattinger, PharmD, PhD
Dominick Patafio, P4 Student –
Bennett Doughty as mentor Poster Presentation: Patel N, Rahman H, Fang Y, Doughty B, Spencer S. “Combating the Opioid Epidemic with Opioid Use Disorder Awareness and Naloxone Training for Rural and Underserved Youth in Upstate New York.” American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting. Las Vegas, Nev. Dec 5, 2022.
Erin Pauling, PharmD
Platform Presentation: Young SR, Hennig KR, Cowen NS, McGinley JM, Pauling EE, Podolak CE, Rattinger GB, Rouhana N, Shipe S. “Impact of an Interprofessional Community-Engaged Poverty Module on Key Learning Outcomes: A Qualitative Analysis of Student Reflections.” Lightning Talk at Nexus Summit 2022. Sept. 14 2022.
Poster Presentation: Vernon K, Gonzalez HL, Schwartz SE, Rattinger GB, Drewel M, Smith KR, DeBerard MS, Kauwe J, Buhusi M, Tschanz JT. “Sex differences in risk for Alzheimer’s disease with extended maternal and paternal family history and vascular risk factors. The Cache County Study.” Alzheimer’s Association International Conference 2022 (AAIC®). San Diego, Cal. July 31 – Aug. 4, 2022. Poster Presentation: Matyi J, Drewel M, Schwartz SE, Rattinger GB, Gonzalez H, DeBerard MS, Buhusi M, Lyketsos CG, Tschanz JT. “Brain-derived neurotrophic factor genes are associated with neuropsychiatric symptom progression in dementia. The Cache County Dementia Progression Study.” Alzheimer’s Association International Conference 2022 (AAIC®). San Diego, Cal. July 31 – Aug. 4, 2022.
Sarah Spinler, PharmD
Platform Presentation: Spinler, SA. “Ongoing Dilemmas with Surveillance and Diagnosis of Atrial Fibrillation.” Heart House Roundtable, American College of Cardiology (ACC). Virtual. Oct. 20, 2022. Platform Presentation: Spinler, SA. “Guidelines Update: Peri-operative Management of Antithrombotic Therapy: ACCP Clinical Practice Guideline.” Continuing education, 1 credit hour. New York State Council of Health-system Pharmacists (NYSCHP) Annual Assembly. Saratoga Springs, N.Y. Apr. 21, 2023. Platform Presentation: Spinler, SA. “Leveraging Medication-Use Evaluations to Optimize Care: Focus on Andexanet alfa.” American Society of Health-System Pharmacists (ASHP). Apr. 25 2023.
L. Nathan Tumey, PhD
Platform Presentation & Poster: Tumey LN. “New Strategies for the Design of TRL7 Agonist ADCs.” World AntibodyDrug Conjugate (World ADC). San Diego, Ca. Sept. 6, 2022. Platform Presentation & Poster: Tumey LN. “Design, synthesis, and evaluation of anti-inflammatory antibody-drug-conjugates (ADCs) that target monocytes and macrophages.” Northeast Regional Meeting (NERM) of the American Chemical Society (ACS). Rochester, N.Y. Oct. 4, 2022. Platform Presentation: Tumey LN. “Dual-Function Antibody Conjugates: Combining Multiple Modes of Action
to Maximize ADC Efficacy.” Protein Engineering Summit (PEGS). Boston, Mass. May 15-19, 2023.
Taylor Warner, P4 Student –
Amanda Mogul as mentor Poster Presentation: Warner T, Garr H, Nguyen N, Studer B, Mogul A. “Evaluating the impact of an at home medication disposal system on safe medication disposal.” American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting. Las Vegas, Nev. Dec. 5, 2022.
Poster Presentation: Williams B, Applebee Z, Zou P, Wang Z, Solano Diaz E, Li Y, Zhang T. “An In Vitro Human Mammary Epithelial Cell Permeability Assay to Assess Drug Secretion into Breast Milk.” American Association of Pharmaceutical Scientists Northeast Regional Discussion Group (AAPS NERDG) Annual Meeting. Queens, New York. March 31, 2023.
Shirley Xu, P4 Student –
Mohammad Ali as mentor Poster Presentation: Xu S, Bouregba M, Farrel K, Young M, Maybee D, Ali MAM. “Role of Matrix Metalloproteinase-2 (MMP-2) in Osteosarcoma Migration.” American Association of Pharmaceutical Scientists Northeast Regional Discussion Group (AAPS NERDG) Annual Meeting. Queens, N.Y. Mar. 30, 2023.
Tao Zhang, PhD
Poster Presentation: Tao Zhang, Peng Zou, Yingsi Fang, Yanyan Li. “Physiologically-Based Pharmacokinetic Model to Predict Milk Drug Concentrations of Breast Cancer Resistance Protein Substrates.” 2022 American Association of Pharmaceutical Scientists (AAPS) PharmSci 360. Boston, MA. Oct. 16-19, 2022. Platform Presentation: Tao Zhang. “Drug Use During Lactation.” American Chinese Pharmaceutical Association (ACPA). Webinar. Mar. 18, 2023.
Samantha Benjamin, PhD student, concentrates on her work in the research lab.
School of Pharmacy and Pharmaceutical Sciences PO Box 6000 Binghamton, NY 13902-6000 96 Corliss Ave. Johnson CIty, N.Y. 13790 binghamton.edu/pharmacy-and-pharmaceutical-sciences
23-524